Despite their potential, nano-diagnostic devices face several challenges. One major issue is scalability. Producing nanomaterials consistently and at a large scale can be difficult and costly. There are also regulatory hurdles to overcome, as these devices must meet stringent safety and efficacy standards before they can be widely adopted. Additionally, there are concerns about the long-term stability and biocompatibility of nanomaterials used in these devices.
